-
EP3943485
European procedure
Extract from the Register of European Patents
EP About this file: EP3943485
| EP3943485 - ARYL- OR HETEROARYL-SUBSTITUTED BENZENE COMPOUNDS [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 01.11.2024 Database last updated on 26.04.2025 | |
| Former | The patent has been granted Status updated on 24.11.2023 | ||
| Former | Grant of patent is intended Status updated on 12.04.2023 | ||
| Former | Examination is in progress Status updated on 30.09.2022 | ||
| Former | Request for examination was made Status updated on 29.07.2022 | ||
| Former | The application has been published Status updated on 24.12.2021 | Most recent event Tooltip | 22.11.2024 | Lapse of the patent in a contracting state New state(s): MC | published on 25.12.2024 [2024/52] | Applicant(s) | For all designated states Epizyme, Inc. 400 Technology Square, 4th Floor Cambridge, MA 02139 / US | [2022/04] | Inventor(s) | 01 /
CHESWORTH, Richard Concord, 01742 / US | 02 /
DUNCAN, Kenneth William Westwood, 02090 / US | 03 /
KEILHACK, Heike Belmont, 02478 / US | 04 /
WARHOLIC, Natalie Auburndale, 02466 / US | 05 /
KLAUS, Christine Weymouth, 02191 / US | 06 /
SEKI, Masashi Tsukubashi, 300-2635 / JP | 07 /
SHIROTORI, Syuji Tsukubashi, 300-2635 / JP | 08 /
KAWANO, Satoshi Tsukubashi, 300-2635 / JP | 09 /
WIGLE, Timothy James Nelson Waltham, 02451 / US | 10 /
KNUTSON, Sarah Kathleen Cambridge, 02138 / US | 11 /
KUNTZ, Kevin Wayne Woburn, 01801 / US | [2022/04] | Representative(s) | Russell, Tim, et al Venner Shipley LLP 200 Aldersgate London EC1A 4HD / GB | [2022/04] | Application number, filing date | 21175920.4 | 13.04.2012 | [2022/04] | Priority number, date | US201161474821P | 13.04.2011 Original published format: US 201161474821 P | US201161499595P | 21.06.2011 Original published format: US 201161499595 P | [2022/04] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP3943485 | Date: | 26.01.2022 | Language: | EN | [2022/04] | Type: | B1 Patent specification | No.: | EP3943485 | Date: | 27.12.2023 | Language: | EN | [2023/52] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 06.10.2021 | Classification | IPC: | C07D213/64, C07D401/12, C07D405/12, C07D409/12, C07D413/12, C07D417/12, C07D491/08, C07D491/107, A61K31/4412, A61K31/444, A61P35/00 | [2022/04] | CPC: |
A61K31/5377 (EP,IL,US);
C07D213/64 (CN,IL,KR,RU,US);
C07D405/14 (CN,IL,KR,US);
A61K31/4412 (EP,KR,RU,US);
A61K31/443 (EP,US);
A61K31/4433 (EP,US);
A61K31/4436 (EP,US);
A61K31/4439 (EP,US);
A61K31/444 (EP,RU,US);
A61K31/4545 (EP,US);
A61K31/4709 (EP,US);
A61K31/496 (EP,US);
A61K31/506 (EP,US);
A61K31/551 (EP,US);
A61K31/553 (EP,US);
A61P35/00 (EP,KR);
A61P35/02 (EP);
A61P43/00 (EP);
C07D213/81 (CN);
C07D401/12 (CN,IL,KR,RU,US);
C07D401/14 (CN,KR);
C07D405/12 (CN,IL,KR,RU,US);
C07D409/12 (CN,IL,KR,RU,US);
C07D413/12 (CN,IL,RU,US);
C07D413/14 (KR);
C07D417/12 (CN,IL,KR,RU,US);
C07D491/08 (CN,IL,RU,US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2022/35] |
| Former [2022/04] | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR | Title | German: | ARYL- ODER HETEROARYLSUBSTITUIERTE BENZOLVERBINDUNGEN | [2022/04] | English: | ARYL- OR HETEROARYL-SUBSTITUTED BENZENE COMPOUNDS | [2022/04] | French: | COMPOSÉS DE BENZÈNE HÉTÉROARYL- OU ARYL- SUBSTITUÉS | [2022/04] | Examination procedure | 25.07.2022 | Amendment by applicant (claims and/or description) | 25.07.2022 | Examination requested [2022/35] | 25.07.2022 | Date on which the examining division has become responsible | 04.10.2022 | Despatch of a communication from the examining division (Time limit: M04) | 03.02.2023 | Reply to a communication from the examining division | 13.04.2023 | Communication of intention to grant the patent | 13.09.2023 | Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time | 17.11.2023 | Fee for grant paid | 17.11.2023 | Fee for publishing/printing paid | 17.11.2023 | Receipt of the translation of the claim(s) | Parent application(s) Tooltip | EP12719529.5 / EP2697199 | EP16172386.1 / EP3150580 | EP18200713.8 / EP3486234 | Divisional application(s) | EP23217912.7 / EP4360712 | Opposition(s) | 30.09.2024 | No opposition filed within time limit [2024/49] | Request for further processing for: | The application is deemed to be withdrawn due to failure to fulfill actions required for granting the patent | 17.11.2023 | Request for further processing filed | 17.11.2023 | Full payment received (date of receipt of payment) Request granted | 27.11.2023 | Decision despatched | Fees paid | Renewal fee | 26.05.2021 | Renewal fee patent year 03 | 26.05.2021 | Renewal fee patent year 04 | 26.05.2021 | Renewal fee patent year 05 | 26.05.2021 | Renewal fee patent year 06 | 26.05.2021 | Renewal fee patent year 07 | 26.05.2021 | Renewal fee patent year 08 | 26.05.2021 | Renewal fee patent year 09 | 26.05.2021 | Renewal fee patent year 10 | 27.04.2022 | Renewal fee patent year 11 | 27.04.2023 | Renewal fee patent year 12 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | HR | 27.12.2023 | MC | 27.12.2023 | RS | 27.12.2023 | SM | 27.12.2023 | [2024/52] |
| Former [2024/33] | HR | 27.12.2023 | |
| RS | 27.12.2023 | ||
| SM | 27.12.2023 | ||
| Former [2024/27] | HR | 27.12.2023 | |
| RS | 27.12.2023 | Documents cited: | Search | [A]WO2009006577 (UNIV MICHIGAN [US], et al); | [YPA]WO2011140325 (GLAXOSMITHKLINE LLC [US], et al); | [YPA]WO2011140324 (GLAXOSMITHKLINE LLC [US], et al) | by applicant | US4522811 | US5763263 | US7563589 |